On Invalid Date, Zimmer Biomet Holdings (NYSE: ZBH) reported Q4 2023 earnings per share (EPS) of $2.02, up 420.63% year over year. Total Zimmer Biomet Holdings earnings for the quarter were $419.20 million. In the same quarter last year, Zimmer Biomet Holdings's earnings per share (EPS) was -$0.63.
As of Q2 2024, Zimmer Biomet Holdings's earnings has grown 346.36% year over year. This is 258.33 percentage points higher than the US Medical Devices industry earnings growth rate of 88.04%. Zimmer Biomet Holdings's earnings in the past year totalled $1.02 billion.
What is ZBH's earnings date?
Zimmer Biomet Holdings's earnings date is Invalid Date. Add ZBH to your watchlist to be reminded of ZBH's next earnings announcement.
What was ZBH's revenue last quarter?
On Invalid Date, Zimmer Biomet Holdings (NYSE: ZBH) reported Q4 2023 revenue of $1.94 billion up 6.3% year over year. In the same quarter last year, Zimmer Biomet Holdings's revenue was $1.83 billion.
What was ZBH's revenue growth in the past year?
As of Q2 2024, Zimmer Biomet Holdings's revenue has grown 6.55% year over year. This is 2.85 percentage points lower than the US Medical Devices industry revenue growth rate of 9.4%. Zimmer Biomet Holdings's revenue in the past year totalled $7.39 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.